Importantly, this upregulation of IGF2BP3 has been associated with the regulation of both total and membrane-bound expression levels of programmed cell death ligand 1 (PD-L1), which has been established to be associated with immune suppression and tumor progression [130]. Here, IGF2BP3 is linked to neoplasm.